111.94
BATS BZX Real-Time Price
As of 11:31am ET
 +0.93 / +0.84%
Today’s Change
103.66
Today|||52-Week Range
132.13
-3.27%
Year-to-Date
3 Top Diabetes Stocks to Watch in August
10:05am / MotleyFool.com - Paid Partner Content
8 Stocks That Have Paid a Dividend for 125 (or More) Consecutive Years
Aug 13 / MotleyFool.com - Paid Partner Content
Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Choice
9:15am / Zacks.com - Paid Partner Content
Intrexon (XON) Reports Narrower-Than-Expected Loss in Q2
Aug 09 / Zacks.com - Paid Partner Content
Bayer Inks $7.6B Deal to Divest Animal Health Unit to Elanco
8:56am / Zacks.com - Paid Partner Content
Nektar (NKTR) Q2 Earnings Beat Estimates, Revenues Miss
Aug 09 / Zacks.com - Paid Partner Content
Bayer Sells Animal Health Division to Elanco: Now What?
Aug 20 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients
Aug 09 / Zacks.com - Paid Partner Content
Better Buy: Eli Lilly vs. GlaxoSmithKline
Aug 18 / MotleyFool.com - Paid Partner Content
Novo Nordisk (NVO) Q2 Earnings & Revenues Beat Estimates
Aug 09 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Pipeline/Regulatory Updates From JNJ, LLY, AZN, RHHBY
Aug 16 / Zacks.com - Paid Partner Content
Top Stock Reports: Disney, Eli Lilly, ADP & More
Aug 08 / Zacks.com - Paid Partner Content
Gilead's (GILD) Filgotinib MAA for RA Accepted in Europe
Aug 16 / Zacks.com - Paid Partner Content
Celldex (CLDX) Q2 Loss Narrower Than Expected, Revenues Miss
Aug 08 / Zacks.com - Paid Partner Content
Agios Rides High on Tibsovo Sales Amid Acute Competition
Aug 15 / Zacks.com - Paid Partner Content
Radius (RDUS) Q2 Earnings Beat Estimates, Tymlos Sales Solid
Aug 08 / Zacks.com - Paid Partner Content
Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?
Aug 14 / Zacks.com - Paid Partner Content
Teva (TEVA) Q2 Earnings, Sales Top Estimates, CFO Steps Down
Aug 08 / Zacks.com - Paid Partner Content
Lilly's Taltz Outshines J&J's Tremfya in Psoriasis Study
Aug 14 / Zacks.com - Paid Partner Content